Dr. Chad Thompson has joined ToxStrategies as a Senior Health Scientist and is based in Houston, Texas. He holds a doctorate degree in Biomedical Sciences from the University of Texas Health Science Center at Houston. Dr. Thompson’s comes to ToxStrategies from the U.S. Environmental Protection Agency where he was involved with IRIS chemical risk assessments, the development of databases for physiological parameters suitable for application in physiologically-based pharmacokinetic (PBPK) modeling, as well as the development of risk assessment practices and policy documents. While at the U.S. EPA, his work also focused on susceptibility issues – including those related to genetics (e.g. polymorphisms), age (e.g. children), and health. He has also collaborated with national and international experts on issues regarding potential mechanisms of formaldehyde toxicity. In addition to his extensive technical background, Dr. Thompson also holds an MBA.
To read more about Dr. Thompson, or to obtain his new contact information, please click here.